VITAMIN D AND TYPE 2 DIABETES MELLITUS：A NARRATIVE REVIEW
WANG Chun-yang1, WEI Fei2, DOU Fei-yan1, HU Zhi-yong1, TAN Feng-he3
Author information+
1School of Public Health, ; 2School of Health Administration, Binzhou Medical University, Yantai 264003, 3The Second Clinical Medical College of Binzhou Medical University, Yantai 264003, China
In recent years, an increasing incidence of type 2 diabetes mellitus (T2DM) was noted worldwide. Many factors were closely related to the occurrence and development of T2DM, among which the role of vitamin D has attracted more and more attention. At present, the correlation between vitamin D deficiency and T2DM has become a hot topic. This article reviews the research progress in the relationship between vitamin D deficiency and T2DM and the possible mechanisms involved, so as to provide some new ideas for the prevention and treatment of T2DM and its complications.
WANG Chun-yang, WEI Fei, DOU Fei-yan, HU Zhi-yong, TAN Feng-he.
VITAMIN D AND TYPE 2 DIABETES MELLITUS：A NARRATIVE REVIEW[J]. Acta Nutrimenta Sinica. 2025, 47(3): 308-312
中图分类号：
R151
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N,#magtechI#et al. Vitamin D and cardiovascular health[J]. Clin Nutr, 2021, 40:2946–2957. [2] Peterlik M, Cross HS.Vitamin D and calcium insufficien-cy related chronic diseases: molecular and cellular pathophysiology[J]. Eur J Clin Nutr, 2009, 63:1377–1386. [3] Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study[J]. Lancet, 2010, 376:180–188. [4] Izzo A, Massimino E, Riccardi G, et al. A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors[J]. Nutrients, 2021, 13:183. [5] Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Res Clin Pract, 2019,157:107843. [6] Zittermann A, Schleithoff SS, Koerfer R.Putting cardiovascular disease and vitamin D insufficiency into perspective[J]. Br J Nutr, 2005, 94:483–492. [7] Zittermann A, Trummer C, Theiler-Schwetz V, et al. Vitamin D and cardiovascular disease: an updated narrative review[J]. Int J Mol Sci, 2021, 22:2896–2896. [8] Shab-Bidar S, Neyestani TR, Djazayery A, ,et al. Vitamin D receptor Cdx-2- dependent response of central obesity to vitamin D intake in the subjects with type 2 diabetes: a randomised clinical trial[J]. Br J Nutr. Vitamin D receptor Cdx-2- dependent response of central obesity to vitamin D intake in the subjects with type 2 diabetes: a randomised clinical trial[J]. Br J Nutr, 2015, 114:1375–1384. [9] Melguizo-Rodríguez L, Costela-Ruiz VJ, García-Recio E, et al. Role of vitamin D in the metabolic syndrome[J]. Nutrients, 2021,13:830. [10] Parker J, Dutton D, Mavrodaris A, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis[J]. Maturita, 2010, 65:225–236. [11] Forouhi NG, Ye Z, Rickard AP, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European prospective investigation into cancer (EPIC)-norfolk cohort and updated meta-analysis of prospective studies[J]. Diabetologia, 2012, 55:2173–2182. [12] Li X, Liu Y, Zheng Y, et al. The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis[J]. Nutrients, 2018,10:375. [13] Taderegew MM, Woldeamanuel GG, Wondie A, et al. Vitamin D deficiency and its associated factors among patients with type 2 diabetes mellitus: a systematic review and meta-analysis[J].BMJ Open,2023,13:e075607. [14] Zhang Y, Tan H, Tang J, et al. Effects of vitamin D supplementation on prevention of type 2 diabetes in patients with prediabetes: a systematic review and meta-analysis[J]. Diabetes Care, 2020,43:1650-1658. [15] Jehle S, Lardi A, Felix B, et al. Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo- controlled, prospective pilot study[J]. Swiss Med Wkly, 2014, 144: 13942. [16] Tabesh M, Azadbakht L, Faghihimani E, et al. Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial[J]. Diabetologia, 2014, 57: 2038–2047. [17] de Boer IH, Tinker LF, Connelly S,#magtechI#et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the women's health initiative[J]. Diabetes Care, 2008, 31:701–707. [18] González-Molero I, Rojo-Martínez G, Morcillo S, et al. Vitamin D and incidence of diabetes: a prospective cohort study[J]. Clin Nutr, 2012, 31:571–573. [19] Lips P, Eekhoff M, van Schoor N, et al. Vitamin D and type 2 diabetes[J]. J Steroid Biochem Mol Biol, 2017, 173:280–285. [20] Wimalawansa SJ.Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome[J]. J Steroid Biochem Mol Biol, 2018,175:177–189. [21] Sentinelli F, Bertoccini L, Barchetta I, et al. The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children[J]. Nutr Metab Cardiovasc Dis, 2016, 26:407–413. [22] Vondra K, Hampl R.Vitamin D and new insights into pathophysiology of type 2 diabetes[J]. Horm Mol Biol Clin Investig, 2021, 42:203–208. [23] Martyushev-Poklad AV, Yankevich DS, Petrova MV, Savitskaya NG.[Hyperinsulinemia and age-related diseases: interrelations and approaches to treatment]. Vopr Pitan. 2022;91(3):21-31. [24] Szymczak-Pajor I, Śliwińska A.Analysis of association between vitamin D deficiency and insulin resistance[J]. Nutrients, 2019, 11:794. [25] Newsholme P, Cruzat VF, Keane KN, et al. Molecular mechanisms of ROS production and oxidative stress in diabetes[J]. Biochem J, 2016, 473:4527–4550. [26] Brownlee M.The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54: 1615–1625. [27] Consiglio M, Viano M, Casarin S, et al. Mitochondrial and lipogenic effects of vitamin D on differentiating and proliferating human keratinocytes[J]. Exp Dermatol, 2015, 24: 748–753. [28] Verdile G, Keane KN, Cruzat VF, et al. Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's disease[J]. Mediators Inflamm, 2015: 1–17. [29] Sergeev IN.1,25-Dihydroxyvitamin D3 and type 2 diabetes: Ca2+-dependent molecular mechanisms and the role of vitamin D status[J]. Horm Mol Biol Clin Investig,2016, 26:61–65. [30] Bánsághi S, Golenár T, Madesh M, et al. Isoform- and species-specific control of inositol 1,4,5-trisphos- phate (IP3) receptors by reactive oxygen species[J]. J Biol Chem, 2014, 289:8170–8181. [31] Ryan ZC, Craig TA, Folmes CD, et al. 1α,25- Dihydroxy- vitamin D3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells[J]. J Biol Chem, 2016, 291:1514–1528. [32] Abbas MA.Physiological functions of vitamin D in adipose tissue[J]. J Steroid Biochem Mol Biol, 2017, 165:369–381. [33] Silvagno F, Consiglio M, Foglizzo V, et al. Mitochon-drial translocation of vitamin D receptor is mediated by the permeability transition pore in human keratinocyte cell line[J]. PLoS One, 2013, 8:e54716. [34] Scaini G, Rezin GT, Carvalho AF, et al. Mitochondrial dysfunction in bipolar disorder: evidence, pathophy- siology and translational implications[J]. Neurosci Biobehav Rev, 2016, 68:694–713. [35] Garbossa SG, Folli F.Vitamin D, sub-inflammation and insulin resistance. a window on a potential role for the interaction between bone and glucose metabolism[J]. Rev Endocr Metab Disord, 2017, 18:243–258. [36] Marcotorchino J, Gouranton E, Romier B, et al. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes[J]. Mol Nutr Food Res, 2012,56: 1771–1782. [37] Gezen-Ak D, Dursun E, Yilmazer S, et al. The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons[J]. PLoS One, 2011, 6:e17553. [38] Guerrero-Hernandez A, Verkhratsky A.Calcium signalling in diabetes[J]. Cell Calcium, 2014, 56:297–301. [39] Alam F, Islam M, Gan S, et al. DNA methylation: an epigenetic insight into type 2 diabetes mellitus[J]. Curr Pharm Des, 2016, 22:4398–4419. [40] Gerber PA, Rutter GA.The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus[J]. Antioxid Redox Signal, 2017, 26:501–518.
PDF(996 KB)
